Weiss Multi-Strategy Advisers’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-23,484
Closed -$235K 834
2021
Q2
$235K Hold
23,484
0.01% 610
2021
Q1
$236K Sell
23,484
-6,266
-21% -$66.7K 0.01% 633
2020
Q4
$312K Buy
+29,750
New +$310K 0.01% 619

Other funds holding MTACU

Weiss Multi-Strategy Advisers's MTACU Position: Q3 2021 in Review

Weiss Multi-Strategy Advisers sold out of MedTech Acquisition Corporation Unit (MTACU) in Q3 2021, closing a stake of 23,484 shares — an estimated $235K sold.

Weiss Multi-Strategy Advisers first reported a position in MTACU in Q4 2020 and held it in 3 quarters. The position peaked at $312K in Q4 2020. 20 funds tracked by Wall St. Rank hold MTACU as of Q3 2021.

  • Weiss Multi-Strategy Advisers reported no remaining MedTech Acquisition Corporation Unit position as of Q3 2021 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 23,484 MedTech Acquisition Corporation Unit shares in Q3 2021, an estimated $235K.
  • Weiss Multi-Strategy Advisers first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 3 quarters.
  • Weiss Multi-Strategy Advisers's MedTech Acquisition Corporation Unit position peaked at $312K in Q4 2020.
  • 20 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q3 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.